Dr. Lee is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
22 S Greene St
Baltimore, MD 21201Phone+1 410-328-8708- Is this information wrong?
Education & Training
University of Texas Health Science Center at Houston/M D Anderson Cancer CenterFellowship, Hematology and Medical Oncology, 2012 - 2015
MontefioreResidency, Internal Medicine, 2009 - 2012
Yonsei University College of MedicineClass of 1990
Certifications & Licensure
MD State Medical License 2015 - 2024
TX State Medical License 2012 - 2016
MA State Medical License 2011 - 2012- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- A Study of Rituximab-Gemcitabine-Dexamethasone-Platinum (R-GDP) With or Without Selinexor in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma Start of enrollment: 2020 Sep 03
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- Clinical outcomes of patients with acute myeloid leukemia and cardiovascular disease.Gabriela Sanchez-Petitto, Olga G Goloubeva, Jack Masur, James Childress, Tahreem Iqbal, Max An, Safwan Muhammad, Justin Lawson, Grace Li, Brian Barr, Ashkan Emadi, Jen...> ;Leukemia Research. 2024 Mar 1
- 3 citationsImaging Biomarkers to Predict Outcomes in Patients With Large B-Cell Lymphoma With a Day 28 Partial Response byF-FDG PET/CT Imaging Following CAR-T Therapy.Lutfi, F., Goloubeva, O., Kowatli, A., Gryaznov, A., Kim, D., Dureja, R., Margiotta, P., Matsumoto, L., Bukhari, A., Ahmed, N., Mushtaq, M., Law, J., Lee, S., Kocoglu,...> ;Clinical Lymphoma, Myeloma & Leukemia. 2023 Oct 1
- Combinatorial Efficacy and Toxicity of an Engineered Toxin Body MT-3724 with Gemcitabine and Oxaliplatin in Relapsed or Refractory Diffuse Large B Cell Lymphoma.Chenyu Lin, Ahmed Galal, David Rizzieri, Sant Chawla, Seung T Lee, Angela Georgy, Kristina Dabovic, Thomas Strack, Matthew McKinney> ;Cancer Investigation. 2023 Jan 31
- Join now to see all
Abstracts/Posters
- A Phase I Study Combining CDK2/9 Inhibitor CYC065 with Venetoclax, a BCL2 Inhibitor, to Treat Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)Seung Tae Lee, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- A Phase I Study Combining CDK2/9 Inhibitor CYC065 with Venetoclax, a BCL2 Inhibitor, to Treat Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)Seung Tae Lee, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Increased Cortical Glycolysis Following CD19 CART Therapy: A Radiographic Surrogate for an Altered Blood-Brain BarrierSeung Tae Lee, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Join now to see all
Other Languages
- Korean
Hospital Affiliations
University of Maryland Medical CenterBaltimore, Maryland
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
